Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013013 · ClinicalTrials.gov registry record · Phase 4
A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 4,000
- Enrollment target
NCT00013013: Completed Phase 4 study, sponsored by US Department of Veterans Affairs.
NCT00013013 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 4,000 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (672% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00013013, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4,000 participants
- Enrollment target
Study Summary
Among veterans, smoking is the single most important risk factor for preventable mortality and morbidity, and studies suggest a higher prevalence of smoking among veterans than the general population. The VHA has encouraged adoption of the AHCPR Guideline for Smoking Cessation, yet most hospitals have poorly developed smoking cessation programs.
Interventions
- PROCEDURE Systems Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Est. Completion | 2001-08 |
| Phase | Phase 4 |
What the finished NCT00013013 record still lists
NCT00013013 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (672% higher).
The record links to 0 conditions, and to 1 intervention - of which Systems Support is the first listed.
NCT00013013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00013013 about?
NCT00013013 is a clinical study titled "A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline". Among veterans, smoking is the single most important risk factor for preventable mortality and morbidity, and studies suggest a higher prevalence of smoking among veterans than the general population. The VHA has encouraged adoption of the AHCPR Guideline for Smoking Cessation, yet most hospitals ha...
What is the current status of trial NCT00013013?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4,000 participants. Estimated completion is 2001-08.
What interventions are being tested in trial NCT00013013?
The interventions under investigation include: Systems Support (PROCEDURE).
Who is sponsoring clinical trial NCT00013013?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00013013's enrollment target sits among peer trials
4,000 20th of 2000 higher than 1,980 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer